Send by MarketWatch (press release)

LLP is conducting an investigation into alleged breaches of fiduciary duties and violations of state law by King Pharmaceuticals, Inc. ("King") [...]

Send by Seeking Alpha

a Hollywood-like conglomerate, the drugmaker has agreed to pay $3.6 billion to buy King Pharmaceuticals (KG), which sells various pain medications. [...]

Send by The Associated Press

King markets one such drug, called Embeda, and it's seeking approval for two others under the names Remoxy and Acurox. Remoxy is similar to Purdue Pharma [...]

Send by Forbes

Shares of King Pharmaceuticals are on the rise on Tuesday after Pfizer said today it has agreed to acquire the company for $14.25 per share, or $3.6 billion [...]

Send by MarketWatch

By MarketWatch SAN FRANCISCO (MarketWatch) — Pfizer Inc. laid claim to King Pharmaceuticals, Inc. Tuesday with an offer that couldn't be refused. [...]

Send by BusinessWeek

AP Moody's Investors Service placed the ratings of King Pharmaceuticals Inc. under review for a possible upgrade following the announcement that Pfizer Inc. [...]

Send by Kansas City Star

buy King Pharmaceuticals, which specializes in pain drugs, in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company. [...]

Send by Forbes

King Pharmaceuticals is the next major acquisition for the US drug company after taking over Wyeth last year. Pfizer reported Tuesday that it will buy King [...]

Send by MSN Money

Pfizer is buying King Pharmaceuticals. Obama lifts drilling moratorium. Intel and CSX report after the bell. Stocks reversed an early decline and finished [...]

Send by Benzinga

Oppenheimer & Co. is out with a research report discussing Pfizer Inc.'s (NYSE: PFE) purchase of King Pharmaceuticals, Inc. (NYSE: KG) yesterday. [...]

Send by MarketWatch (press release)

LLC announces that it is investigating potential claims against the Board of Directors of King Pharmaceuticals, Inc ("King") or the "Company") (NYSE:KG) [...]

Send by Wall Street Journal

Among the companies whose shares are actively trading in the session are King Pharmaceuticals Inc. (KG), Avon Products Inc. (AVP) and Global Payments Inc. [...]

Send by The Associated Press

King markets one such drug, called Embeda, and it's seeking approval for two others under the names Remoxy and Acurox. Remoxy is similar to Purdue Pharma [...]

Hoovers company profile of King Pharmaceuticals, Inc.. Find detailed business information such as key executives, financials and other corporate data on [...]

View the basic KG stock chart on Yahoo! Finance. Change the date range, chart type and compare King Pharmaceuticals, Inc. Comm against other companies. [...]

King Pharmaceuticals is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily [...]

12 Oct 2010 Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the [...]

Contact Us. Main Numbers: 1 (800) 776-3637; 1 (423) 989-8000. Mailing Address. King Pharmaceuticals,® Inc. 501 Fifth Street Bristol, Tennessee 37620 [...]

12 Oct 2010 Pfizer, the world's largest drug company by revenues, has agreed to buy King Pharmaceuticals, a maker of prescription pain treatments, [...]

Send by fatmady

kg King Pharmaceuticals @ Year Highs Nеw York, October 12th (TradersHuddle.com) – Shares οf King Pharmaceuticals, Inc. (NYSE:KG) booked a nеw 52 week high today bу trading above $13.2, traders аrе сеrtаіnlу monitoring King [...]

Send by Wall Street Journal

By MARKET DATA STAFF King Pharmaceuticals Inc. topped the list for Selling on Strength , which tracks stocks that rose in price but had the largest outflow [...]

Send by tom543z

Pfizer finalised a $3.6 billion deal and added King Pharmaceuticals Inc. (KG) as their new partners. King Pharmaceuticals are specialists of pain-reliefs and this news came in just before the opening session of Tuesday. [...]

Send by MarketNewsVideo.com

Shares of King Pharmaceuticals (NYSE:KG) are on the rise on Tuesday after Pfizer (PFE) said today it has agreed to acquire the company for $14.25 per share, [...]

Send by king pharmaceuticals - Google

Google, King Pharma, ActivIdentity Rise; Global Payments Fall123Jump.comKing Pharmaceuticals soared on a takeover agreement with Pfizer. Global Payments Inc dropped on lower than expected earnings. Of the stocks in the Dow, [...]

Stock Market Today - Pfizer buys King PharmaceuticalsPfizer Inc. (PFE) has reached an agreement to acquire buy King Pharmaceuticals Inc. (KG) for $3.6 bn in cash. The deal is expected to soften the loss of market exclusivity for Lipitor, Pfizer's blockbuster treatment. The price of $14.25 per King s [...]